Mumbai: India's largest drugmaker Sun Pharmaceutical Industries Ltd said on Tuesday that U.S. regulators plan to lift a ban on its Mohali plant in Punjab, allowing the company to restart supplies from there after four years. Sun gained the plant along with ... Sify, 1 week ago
USFDA to lift import ban on Sun Pharma's Mohali plant - Business Standard, 1 week ago
India's generic drugmaking industry is getting wheeled out of intensive care. But is it really going home? The US Food and Drug Administration this week lifted the import ban on a factory that Mumbai-based Sun Pharmaceutical Industries inherited as part of ...The Financial Chronicle, 4 days ago
E Kumar Sharma New Delhi Last Updated: January 18, 2017 | 16:43 IST On January 10th, in a 100 word press release, Japanese pharma major Daiichi Sankyo announced that the company had decided to "to close its research subsidiary, Daiichi Sankyo India Pharma ...Money Today, 2 months ago
Mumbai - The Indian stock market suffered losses on four of the five sessions last week (December 19 - 23, 2016), as investors were wary of picking up stocks due to weakness in global markets and on lingering concerns about near term economic outlook due to ...Sify, 2 months ago
on your WebpageAdd Widget >Get your members hooked!